ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;62:1328
© 1996 The Society of Thoracic Surgeons

Discussion

Discussion

The first 20% of the full text of this article appears below.

See also page 1321.

DR PEER M. PORTNER (Stanford, CA): I congratulate Dr Slater and his colleagues for their excellent results and a nicely presented paper.

The issue of thrombogenicity is, as you know, a complex, multifactorial issue that extends beyond the blood-contacting surface of the device. It includes aspects of the flow, not only in the pump itself but also in the conduits, the valves, and other parts of the system, and of course the coagulation state. Based on the fact that this . . . [Full Text of this Article]


Related Article

Low Thromboembolic Risk Without Anticoagulation Using Advanced-Design Left Ventricular Assist Devices
James P. Slater, Eric A. Rose, Howard R. Levin, O. H. Frazier, J. Kirk Roberts, Alan D. Weinberg, and Mehmet C. Oz
Ann. Thorac. Surg. 1996 62: 1321-1327. [Abstract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.